Ulrike Kirsten Buchwald
18PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Jan 28, 2026
Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites.Laura L Hammitt, Ulrike K Buchwald, Jennifer McCauley
|Nov 10, 2025
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8.Paul T Scott, Jayani Pathirana, Akira Kato
|Aug 28, 2025
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974.Kristen Feemster, William P Hausdorff, Natalie Banniettis
|May 07, 2025
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10).Veronika Jotterand, Vinita Jagannath, Andrea Accini Diaz
|Feb 26, 2025
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age.Tosin Omole, Enrique Pelayo, Aaron S Weinberg
Pageof 3
Frequent Collaborators
4 joint publications
Luwy Musey
3 joint publications
Alejandra Esteves-Jaramillo
2 joint publications
Aaron S Weinberg
2 joint publications
Priscilla Velentgas
2 joint publications
William P Hausdorff
1 joint publications
Cassidy W Claassen
1 joint publications
Darwin Dorestan
1 joint publications
Sandra Medina-Moreno
1 joint publications
Robert R Redfield
1 joint publications
Leonard A Sowah
